These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 19694438)

  • 1. Consumption of yerba mate ( Ilex paraguariensis ) improves serum lipid parameters in healthy dyslipidemic subjects and provides an additional LDL-cholesterol reduction in individuals on statin therapy.
    de Morais EC; Stefanuto A; Klein GA; Boaventura BC; de Andrade F; Wazlawik E; Di Pietro PF; Maraschin M; da Silva EL
    J Agric Food Chem; 2009 Sep; 57(18):8316-24. PubMed ID: 19694438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fractionation of aluminum in commercial green and roasted yerba mate samples ( Ilex paraguariensis St. Hil.) and in their infusions.
    Gomes da Costa AM; Nogami EM; Visentainer JV; de Souza NE; Garcia EE
    J Agric Food Chem; 2009 Jan; 57(1):196-200. PubMed ID: 19055364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yerba mate (Ilex paraguariensis) enhances the gene modulation and activity of paraoxonase-2: in vitro and in vivo studies.
    Fernandes ES; Machado Mde O; Becker AM; de Andrade F; Maraschin M; da Silva EL
    Nutrition; 2012; 28(11-12):1157-64. PubMed ID: 22964087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yerba mate (Ilex paraguariensis) improves microcirculation of volunteers with high blood viscosity: a randomized, double-blind, placebo-controlled trial.
    Yu S; Yue Sw; Liu Z; Zhang T; Xiang N; Fu H
    Exp Gerontol; 2015 Feb; 62():14-22. PubMed ID: 25562195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of mate tea (Ilex paraguariensis) intake and dietary intervention and effects on oxidative stress biomarkers of dyslipidemic subjects.
    Boaventura BC; Di Pietro PF; Stefanuto A; Klein GA; de Morais EC; de Andrade F; Wazlawik E; da Silva EL
    Nutrition; 2012 Jun; 28(6):657-64. PubMed ID: 22578980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypocholesterolaemic and antioxidant effects of yerba mate (Ilex paraguariensis) in high-cholesterol fed rats.
    Bravo L; Mateos R; Sarriá B; Baeza G; Lecumberri E; Ramos S; Goya L
    Fitoterapia; 2014 Jan; 92():219-29. PubMed ID: 24291756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylxanthines and phenolics content extracted during the consumption of mate (Ilex paraguariensis St. Hil) beverages.
    Meinhart AD; Bizzotto CS; Ballus CA; Poloni Rybka AC; Sobrinho MR; Cerro-Quintana RS; Teixeira-Filho J; Godoy HT
    J Agric Food Chem; 2010 Feb; 58(4):2188-93. PubMed ID: 20058928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxypropylmethylcellulose lowers cholesterol in statin-treated men and women with primary hypercholesterolemia.
    Maki KC; Carson ML; Miller MP; Anderson WH; Turowski M; Reeves MS; Kaden V; Dicklin MR
    Eur J Clin Nutr; 2009 Aug; 63(8):1001-7. PubMed ID: 19209184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiobesity effects of yerba maté extract (Ilex paraguariensis) in high-fat diet-induced obese mice.
    Arçari DP; Bartchewsky W; dos Santos TW; Oliveira KA; Funck A; Pedrazzoli J; de Souza MF; Saad MJ; Bastos DH; Gambero A; Carvalho Pde O; Ribeiro ML
    Obesity (Silver Spring); 2009 Dec; 17(12):2127-33. PubMed ID: 19444227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mate tea (Ilex paraguariensis) improves glycemic and lipid profiles of type 2 diabetes and pre-diabetes individuals: a pilot study.
    Klein GA; Stefanuto A; Boaventura BC; de Morais EC; Cavalcante Lda S; de Andrade F; Wazlawik E; Di Pietro PF; Maraschin M; da Silva EL
    J Am Coll Nutr; 2011 Oct; 30(5):320-32. PubMed ID: 22081618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yerba Maté (Ilex paraguariensis) aqueous extract decreases intestinal SGLT1 gene expression but does not affect other biochemical parameters in alloxan-diabetic Wistar rats.
    Oliveira DM; Freitas HS; Souza MF; Arçari DP; Ribeiro ML; Carvalho PO; Bastos DH
    J Agric Food Chem; 2008 Nov; 56(22):10527-32. PubMed ID: 18942839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia.
    Bays HE; Davidson M; Jones MR; Abby SL
    Am J Cardiol; 2006 Apr; 97(8):1198-205. PubMed ID: 16616026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LDL-C/HDL-C ratio in subjects with cardiovascular disease and a low HDL-C: results of the RADAR (Rosuvastatin and Atorvastatin in different Dosages And Reverse cholesterol transport) study.
    Jukema JW; Liem AH; Dunselman PH; van der Sloot JA; Lok DJ; Zwinderman AH
    Curr Med Res Opin; 2005 Nov; 21(11):1865-74. PubMed ID: 16307708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pooled analyses of effects on C-reactive protein and low density lipoprotein cholesterol in placebo-controlled trials of ezetimibe monotherapy or ezetimibe added to baseline statin therapy.
    Pearson TA; Ballantyne CM; Veltri E; Shah A; Bird S; Lin J; Rosenberg E; Tershakovec AM
    Am J Cardiol; 2009 Feb; 103(3):369-74. PubMed ID: 19166691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LDL cholesterol lowering by bile acid malabsorption during inhibited synthesis and absorption of cholesterol in hypercholesterolemic coronary subjects.
    Gylling H; Miettinen TA
    Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):19-23. PubMed ID: 12125225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of a dietary portfolio diet of cholesterol-lowering foods and a statin on LDL particle size phenotype in hypercholesterolaemic participants.
    Gigleux I; Jenkins DJ; Kendall CW; Marchie A; Faulkner DA; Wong JM; de Souza R; Emam A; Parker TL; Trautwein EA; Lapsley KG; Connelly PW; Lamarche B
    Br J Nutr; 2007 Dec; 98(6):1229-36. PubMed ID: 17663803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
    Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW;
    Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.